Sarah Barlow

Professor
Pediatrics, Department of Clinical Science
UT Southwestern Medical Center
United States of America

Professor Pediatrics
Biography

Dr. Sarah Barlow received her medical degree from UT Southwestern. She completed her pediatric residency at Brown University, Providence, Rhode Island, and she underwent fellowship training in pediatric gastroenterology and nutrition at Tufts School of Medicine, Floating Hospital for Children in Boston, MA. She also earned a Masters in Public Health at Harvard School of Public Health in 1996. She was board certified in pediatric gastroenterology by the American Board of Pediatrics in 1997. Dr. Barlow was assistant professor of pediatrics at Saint Louis University from 1998 to 2007, where she established a weight management program. In 2007, she joined the faculty at Baylor College of Medicine as associate professor of pediatrics and was the director of the Texas Children’s Hospital Center for Childhood Obesity. She was an investigator on the Texas Childhood Obesity Research Demonstration project, a study sponsored by the CDC that examined healthcare, school, and early childhood education programs for obesity prevention and care in low income neighborhoods. She was the site principal investigator for the NIDDK-sponsored NASH Clinical Research Network (2013-2016). She joined the pediatrics faculty at UT Southwestern Medical Center in 2016. In addition to caring for gastrointestinal conditions, Dr. Barlow oversees an integrated program in obesity care that spans community programs, primary healthcare and tertiary care.

Research Intrest

Management of obesity in children and adolescents NAFLD in children and adolescents Population health approaches to child and adolescent obesity

List of Publications
In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis. Africa JA, Behling CA, Brunt EM, Zhang N, Luo Y, Wells A, Hou J, Belt PH, Kohil R, Lavine JE, Molleston JP, Newton KP, Whitington PF, Schwimmer JB Clin. Gastroenterol. Hepatol. 2017 Mar
Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children. Newton KP, Feldman HS, Chambers CD, Wilson L, Behling C, Clark JM, Molleston JP, Chalasani N, Sanyal AJ, Fishbein MH, Lavine JE, Schwimmer JB J. Pediatr. 2017 Mar
Featured Publications Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: a randomized, double-blind, placebo-controlled trial. McCandless SE, Yanovski JA, Miller J, Fu C, Bird LM, Salehi P, Chan CL, Stafford D, Abuzzahab MJ, Viskochil D, Barlow SE, Angulo M, Myers SE, Whitman BY, Styne D, Roof E, Dykens EM, Scheimann AO, Malloy J, Zhuang D, Taylor K, Hughes TE, Kim DD, Butler MG Diabetes Obes Metab 2017 May